Table 1 Perioperative and postoperative results of the patients
Variables | TPFF coverage (n = 53) | Non-coverage (n = 134) | p value |
|---|---|---|---|
Age, years (mean ± SD) | 62.83 | 60.60 | 0.064 |
Gender | 0.108 | ||
Male | 44 (83.0) | 126 (94.0) | |
Female | 9 (17.0) | 8 (6.0) | |
Operative side [n (%)] | 0.042 | ||
Left | 45 (84.9) | 94 (70.1) | |
Right | 8 (15.1) | 40 (29.9) | |
Co-morbidities [n (%)] | 0.346 | ||
Diabetes | 11 (20.8) | 15 (11.2) | |
Cardiac disorder | 2 (3.8) | 10 (7.5) | |
Hypertension | 4 (7.5) | 6 (4.5) | |
Multiple | 3 (5.7) | 7 (5.2) | |
None | 33 (62.3) | 96 (73.1) | |
FEV1 (lt) | 2.14 ± 0.56 | 2.26 ± 0.56 | 0.187 |
FEV1 (%) | 75.23 ± 14.25 | 84.43 ± 78.56 | 0.403 |
Preoperative serum albümine (mean ± SD) | 4.28 ± 0.70 | 4.08 ± 0.45 | 0.023 |
Neoadjuvant therapy [n (%)] | 0.176 | ||
No | 35 (68.6) | 105 (78.9) | |
Yes | 16 (31.4) | 28 (21.1) | |
Operation time (minutes) (mean ± SD) | 224.53 ± 73.53 | 200.65 ± 95.91 | 0.101 |
Drainage time (days) (mean ± SD) | 3.72 ± 2.24 | 3.92 ± 2.48 | 0.673 |
Hospitalization time (days) (mean ± SD) | 5.92 ± 3.39 | 6.27 ± 3.23 | 0.592 |
Tumor size (mean ± SD) | 5.21 ± 2.16 | 5.23 ± 2.31 | 0.951 |
Surgical margin to the main bronchus | 2.51 ± 1.82 | 2.13 ± 1.42 | 0.180 |
Adjuvant chemotherapy [n (%)] | 0.621 | ||
No | 22 (41.5) | 50 (37.6) | |
Yes | 31 (58.5) | 83 (62.4) | |
Adjuvant radiotherapy [n (%)] | 0.424 | ||
No | 33 (78.6) | 65 (84.4) | |
Yes | 9 (21.4) | 12 (15.6) | |
Pathological stage [n (%)] | 0.238 | ||
Stage I | 8 (15.1) | 11 (12.6) | |
Stage II | 15 (28.3) | 37 (42.5) | |
Stage III | 30 (56.6) | 39 (44.8) | |
BPF [n (%)] | 0.044 | ||
No | 52 (98.1) | 119 (88.8) | |
Yes | 1 (1.9) | 15 (11.2) |